Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sanchitongshu Plus Aspirin for Minor Ischemic Stroke or TIA
NCT02975076Unknown
- Sponsor
- Xinhua Hospital
- Start
- Dec 2016
- Primary completion
- Nov 2019
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of sanqi tongshu in ischemic stroke and Transient Ischemic Attack (TIA) (2 arms), sponsored by Xinhua Hospital. Primary endpoint: Percentage of patients with the 180-day new vascular events. Status: unknown.
02
Drugs
sanqi tongshu
03
Conditions
ischemic strokeTransient Ischemic Attack (TIA)
Beyond the preview
Go deeper on NCT02975076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02975076.